High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.
In a prospective trial of aerosolized pentamidine as secondary prophylaxis for Pneumocystis carinii pneumonia (PCP) 18 patients received 400 mg once weekly for a mean period of 15.5 months. Pentamidine aerosol was administered with an MA2 jet nebulizer. No PCP relapses were observed and no serious side effects occurred.
Flamholc
L
L
Dept. of Infectious Diseases, Malmö General Hospital, University of Lund, Sweden.
Haidl
S
S
Westin
E
E
Borgdalen
L
L
Prellner
T
T
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000336:Aerosols; D006801:Humans; D008297:Male; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D011446:Prospective Studies
D000336:Aerosols; D010419:Pentamidine